RenovoRx Analyst Price Targets - Benzinga

RenovoRx Inc

RNXTNASDAQ

Trade with Public

Trade with Public

$1.58

0.031.94%

最終更新: Oct 2, 7:15 AM

$1.61

0.063.87%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

RenovoRx Analyst Price Targets - Benzinga

RenovoRx Analyst Price Targets

Wall Street analyst price targets and consensus rating for RenovoRx (RNXT).

Price Target Range — 11 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$7Upside to Avg. PT+345.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 28, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$14→$15
Jun 1, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$14→$14
Apr 9, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$13→$14
Apr 8, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Feb 17, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$13→$13
Nov 21, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$12→$13
Aug 25, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$12→$12
Jun 5, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$11→$12
May 19, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Apr 28, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$9→$11
Apr 4, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Mar 27, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Initiate	Buy	$3
Dec 10, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$8→$9
Sep 12, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$8→$8
Jun 17, 2024	Ascendiant Capital	Edward Woo	Initiate	Buy	$8
Feb 2, 2024	Alliance Global Partners	Scott Henry	Initiate	Buy	$4
Nov 15, 2023	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $14.5

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $14 to $14.5.

Benzinga Newsdesk

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $14

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $13.5 to $14.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $13.5

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $13 to $13.5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on RenovoRx, Maintains $3 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates RenovoRx (NASDAQ:RNXT) with a Buy and maintains $3 price target.

Benzinga Newsdesk

Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor